Michael J. Higgins - 25 Mar 2025 Form 4 Insider Report for Cyclerion Therapeutics, Inc. (CYCN)

Reporting relationship: Director
Issuer ticker: CYCN
Reported as of: 25 Mar 2025
Net transaction value: +$24,998
SEC form: 4
Accepted by SEC: 27 Mar 2025, 16:20:44 UTC
Prior SEC filing: 10 Oct 2024
Next SEC filing: 04 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Michael J. Higgins

Key filing fact

Michael J. Higgins filed Form 4 for Cyclerion Therapeutics, Inc. (CYCN) on 27 Mar 2025.

Key facts

This page summarizes Michael J. Higgins's Form 4 filing for Cyclerion Therapeutics, Inc. (CYCN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 Mar 2025, 16:20.

Change

Previous filing in this sequence was filed on 10 Oct 2024.
Current net transaction value: +$24,998.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CYCN transaction

Common Stock

Award

Transaction value: $24,998
Shares: +9,090
Change %: +42%
Price: $2.75
Shares after: 30,740
Date: 25 Mar 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On March 25, 2025, the reporting person purchased directly from the Issuer 9,090 shares of Common Stock for a total purchase price of approximately $25,000 (or $2.75 per share) in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 21, 2025 by and among the Issuer and the investors named therein.